SPRIG Equity is a growth equity and late-stage venture capital firm dedicated to improving patient outcomes by partnering with best-in-class teams and technologies in the medical technology sector. We collaborate with leading innovators who are treating the most pressing challenges faces our healthcare system in the diagnostics, and digital health / tech-enabled services, and medical device sectors. SPRIG Equity is the natural extension of SPRIG Consulting, a premier HealthTech strategy and marketing consulting firm. This partnership allows us to leverage proprietary deal flow and an excellent track record to partner with companies best positioned to solve unmet needs. Having spent our careers viewing challenges from different vantage points, our entire team has unique insights that allow us to provide more than just capital to investments.
Employees: 1-10
Founded date: 2022
Investment Type: Venture Capital
Investment Stage: Series B; Series C; Series D; Series E; Series F; Series G; Series H
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 12.08.2025 | SetPoint M... | setpointmedical.com | $327M | United Sta... |
Mentions in press and media 1
| Date | Title | Description |
| 12.08.2025 | SetPoint Medical: $140 Million Raised To Develop Therapies For Chronic Autoimmune Diseases | SetPoint Medical, focused on therapies for chronic autoimmune diseases, raised $140 million in private funding—$25 million from its Series C and $115 million from its Series D rounds, co-led by Elevage Medical Technologies and Ally Bridge G... |